Healthcare Industry News CSR News

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

Addressing COVID-19 in Vulnerable Diamond and Gold Mining Communities

Mobilizing the Central African Republic mining community to combat the impacts of COVID-19
Blog

This piece was written by Terah DeJong, technical deputy for the U.S. Agency for International Development (USAID) Artisanal Mining and Property Rights (AMPR) project, implemented by Tetra Tech.

This post originally ran on LandLinks.

“I Was Working on a Potential COVID-19 Vaccine—Then My Wife Got Sick”: Meet a Researcher Whose Personal Experience Is Fueling His Fight Against the Pandemic

Within a matter of weeks, Ramon Polo's work and home life were completely changed by the novel coronavirus—and he's a stronger scientist and husband for it.
Blog

In late January—weeks before many people had even heard of the novel coronavirus—Ramon Polo, PharmD, Ph.D., started to work on finding solutions to fight the virus, which data suggested had the potential to become a global pandemic.

As the Vice President of Regulatory Affairs for Infectious Diseases and Vaccines and Global Public Health at Johnson & Johnson, Dr. Polo quickly began to focus on working with healthcare authorities across the globe to collaborate on the development of both therapeutic treatments and a potential vaccine for the rapidly spreading novel coronavirus.

The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 2, Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.

The Road to a Vaccine, Season 2, Ep. 1: How Lessons Learned in Fighting HIV Help Us Battle COVID-19

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In the Season 2 premiere, Lisa Ling checks into the AIDS 2020 conference to talk with HIV advocate Laverne Cox and Johnson &. Johnson Chief Scientific Officer Paul Stoffels, M.D., about how HIV vaccine research is informing work on COVID-19 vaccines.

Medtronic: Leadership During the COVID-19 Crisis

Medtronic CEO talks with TriplePundit about delivering on our Mission during a pandemic
Article

CEO Geoff Martha was recently interviewed by TriplePundit about the company's response to COVID-19. Watch clips of the conversation, where he discusses how our Mission guided him and empowered us to put purpose over profit in a time of crisis.

Watch clips here.

Medtronic: Remotely, Together

Though we are separated by distance, the world is coming together to fight coronavirus
Article

Coronavirus reminds us how our economies, industries, rituals, and life as we know it, exist in a delicate balance. What happens in one corner of the world inevitably impacts another. And seemingly overnight, those connections start to unravel. So while we continue to search for answers, we must find ways to help put things back together.

"AIDS Won't Stop for COVID-19": Meet 3 Inspiring Women Who Are as Committed as Ever to Making HIV History

Summary: 

As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.

Blog

As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.

#BacktheFrontline: Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson

Multimedia with summary

Accelerated innovation. Resources in the hands of health workers. Profit returned to the frontline.

Learn more about how we #BackTheFrontline by investing in innovators developing scalable solutions to COVID-19 from Johnson & Johnson Impact Ventures Chair Joe Wolk.

Follow along with us on @JNJGlobalHealth on Twitter and/or Instagram to hear from our leaders, employees and partners around the world about how YOU can meaningfully contribute.

Safety Month: Committed to Being Safer and Stronger Together

Wrapping up our 10th annual Safety Month celebration
Article

Throughout June, our employees displayed their commitment to being Safer and Stronger Together, making our 10th annual Safety Month a huge success. This month is a time to reinforce our Health & Safety practices that support a strong safety culture year-round. As we reflect on Safety Month, let’s look for ways to incorporate what we learned in our daily work and lives.

Pages

Subscribe to Healthcare Industry News